by Scott Larrivee | Jan 22, 2025 | Podcast
On our first episode of ‘Talk Radioisotopes: Going Nuclear on Cancer,’ host Scott Larrivee is joined by co-host Dr. Sarah Scouten and guest Jeff Jones of Oppenheimer & Company.The discussion covers the latest trends in the radiopharmaceutical and...
by Scott Larrivee | Dec 9, 2024 | News
VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody radiopharmaceuticals for solid...
by Scott Larrivee | Dec 3, 2024 | News
VALENCIA, Calif. – Dec. 3, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the creation of a Medical Radioisotopes Advisory Board. This panel of internationally recognized leaders in nuclear medicine will provide...
by Scott Larrivee | Nov 12, 2024 | News
VALENCIA, Calif. – November 12, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at William Blair’s Innovators Series: Radiopharmaceuticals virtual event on Thursday, November 14,...
